DA
VBIV

DCF Advisers’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

DCF Advisers’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-867
Closed -$81K – 123
2021
Q1 		$81K Sell
867
-333
-28% -$33.8K 0.04% 101
2020
Q4 		$99K Buy
1,200
+317
+36% +$27K 0.04% 89
2020
Q3 		$76K Buy
+883
New +$103K 0.04% 85

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

DCF Advisers's VBIV Position: Q2 2021 in Review

DCF Advisers sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2021, closing a stake of 867 shares — an estimated $81K sold.

DCF Advisers first reported a position in VBIV in Q3 2020 and held it in 3 quarters. The position peaked at $99K in Q4 2020. 134 funds tracked by Wall St. Rank hold VBIV as of Q2 2021.

  • DCF Advisers reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2021 after selling out during the quarter.
  • DCF Advisers sold 867 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2021, an estimated $81K.
  • DCF Advisers first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2020 and held it in 3 quarters.
  • DCF Advisers's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $99K in Q4 2020.
  • 134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2021.

Based on DCF Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.